JAK2 V617F ‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - May 16, 2018 Category: Hematology Authors: Jason Aynardi , Rashmi Manur , Paul R. Hess , Seble Chekol , Jennifer J. D. Morrissette , Daria Babushok , Elizabeth Hexner , Heesun J. Rogers , Eric D. Hsi , Elizabeth Margolskee , Attilio Orazi , Robert Hasserjian , Adam Bagg Source Type: research